UnitedHealth Group Incorporated (NYSE:UNH) surged +2.11% and closed the trade at $ 138.47. The company recorded a trading capacity of 7.42 million shares above its three months average daily volume of 2.96 million shares. During the last trade, shares reached to high price of $138.55 and touched the low price of $135.53. The stock’s 50-day moving average is noted at $139.85 and its 200-day moving average is stands at $134.55.
Additionally, the company has a PE ratio of 21.67 and has EPS of 6.39. The company has market capitalization of $131.88B.
Currently UnitedHealth Group Incorporated (UNH) captured an average recommendation of “ Buy ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “20″ Analysts”. “0” rated “Sell” for the company. “3” said the company as a “Hold”. Overweight rating was given by “2” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $160.55 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $184.00 however minimum price target advised by analysts is $116.00. The Median price target for the stock is measured at $164.00.
Presently, Analysts decided consensus EPS estimate of $2.08 for present quarter and one month ago projected EPS estimate was at $2.08. If we take a look at back 3 month ago, consensus EPS estimate was $2.14.
A current consensus EPS estimate for next quarter is at $2.08 and 3 month ago EPS forecast was $2.04. Have a look at back 1 month ago, consensus EPS forecast was seen at $2.07.
For current fiscal year, most recent EPS estimate is set at $7.93 based on Analyst consensus and three month ago consensus EPS opinions was at $7.89. During period one month ago, consensus EPS forecast was decided at $7.93.
A current consensus EPS projection for next fiscal year is observed at $9.11 and one month ago consensus EPS forecast was at $9.11. Take a look at back three month ago, consensus EPS estimate opinions was decided at $8.99 by analysts.
One Month ago, the stock has gained consensus mean rating of Buy based on the analysis of brokerage analyst firms polled. 22 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 2. 3 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Buy derived from brokerage firms, according to FactSet. 21 said a “Buy Rating” and 2 announced “Overweight Rating”. 4 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.